Skip to main content
Brenda Hill

Featured Patient Story

Brenda Hill

read more

Latest News Story Headlines

2024 Fall Newsletter
Be sure to catch up on the latest happenings in our fall newsletter.
read full article
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug.

read full article
Alnylam Reports Positive Topline Results from HELIOS-B Phase 3 Study of Vutrisiran, Achieving Statistical Significance on Primary and All Secondary Endpoints in Both Overall and Monotherapy Populations

Jun 24, 2024

read full article

Calendar & Upcoming Events

Webinar: Amyloidosis: Effective Paient-Doctor Communications

Webinar Session, Wednesday, October 2, 2024 at 6 PM (ET)

view all event details

Webinar: Updates in AL amyloidosis: Fast Forward in 2024!

Webinar:  Updates in AL amyloidosis: Fast Forward in 2024!

Speaker:  Dr. Heather Landau, MD  Memorial Sloan Kettering Cancer Center

view all event details

Amyloidosis Videos

Our Latest Webinar

UPDATES IN ATTR CARDIAC AMYLOIDOSIS: What's new and exciting for 2024

Frederick L. Ruberg, MD, Omar K. Siddiqi, MD – Boston Medical Center/Boston University – Boston, MA

Sign Up for the Latest Updates

Get news from Amyloidosis Foundation
in your inbox

By submitting this form, you are consenting to receive marketing emails from : Amyloidosis Foundation, 7151 N. Main St., Suite 2, Clarkston, MI, 48346, US, https://www.amyloidosis.org. You can revoke your consent to receive emails at any time by using SafeUnsubscribe© link, found at the bottom of every email. Emails are serviced by Constant Contract.